Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice

Starting Parkinson’s disease (PD) patients on subcutaneous apomorphine (APO) infusion is generally undertaken on a hospital day-case basis. During the COVID-19 pandemic, day-case facilities were unavailable. To avoid delays in treatment, a new procedure was developed for initiation of APO therapy in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobylecki, Christopher, Partington-Smith, Lucy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Neurology and Preclinical Neurological Studies - Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645639/
https://www.ncbi.nlm.nih.gov/pubmed/37870634
http://dx.doi.org/10.1007/s00702-023-02710-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645639/
https://www.ncbi.nlm.nih.gov/pubmed/37870634
http://dx.doi.org/10.1007/s00702-023-02710-w

Ejemplares similares